However, these biological actions that are driven by the HGF–Met pathway all play a role in the acquisition of the malignant characteristics in tumor cells—invasion, metastasis, and drug resistance in the tumor microenvironment (Figure 3). This evidence concerns the gene MET and neoplasm.